AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 >>
Results: 51-75/100
MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - A DISTINCTCLINICO-BIOLOGIC ENTITY WITH POOR-PROGNOSIS
Authors: AMADORI S VENDITTI A DELPOETA G STASI R BUCCISANO F BRUNO A TAMBURINI A COX MC MAFFEI L ARONICA G SIMONE MD ADORNO G MASI M TRIBALTO M PAPA G
Citation: S. Amadori et al., MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - A DISTINCTCLINICO-BIOLOGIC ENTITY WITH POOR-PROGNOSIS, Annals of hematology, 72(4), 1996, pp. 208-215
PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE
Authors: VIGNETTI M ORSINI E PETTI MC MOLETI ML ANDRIZZI C PINTO RM AMADORI S MELONI G
Citation: M. Vignetti et al., PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE, Annals of oncology, 7(9), 1996, pp. 933-938
A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA
Authors: AMADORI S PICARDI A FAZI P TESTI AM PETTI MC MONTEFUSCO E MANDELLI F
Citation: S. Amadori et al., A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 10(5), 1996, pp. 766-768
INTERLEUKIN-3 PLUS LOW-DOSE CYTOSINE-ARABINOSIDE FOR ADVANCED MYELODYSPLASIA - A PILOT-STUDY
Authors: GERHARTZ HH ZWIERZINA HH WALTHER J FENAUX P HAYAT M JACOBS A HOFFBRAND AV DARDENNE M SOLBU G SUCIU S AMADORI S WILLEMZE R
Citation: Hh. Gerhartz et al., INTERLEUKIN-3 PLUS LOW-DOSE CYTOSINE-ARABINOSIDE FOR ADVANCED MYELODYSPLASIA - A PILOT-STUDY, Cancer investigation, 14(4), 1996, pp. 299-306
ANAPLASTIC LARGE-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC EVALUATION OF 90 ADULT PATIENTS
Authors: ZINZANI PL BENDANDI M MARTELLI M FALINI B SABATTINI E AMADORI S GHERLINZONI F MARTELLI MF MANDELLI F TURA S PILERI SA
Citation: Pl. Zinzani et al., ANAPLASTIC LARGE-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC EVALUATION OF 90 ADULT PATIENTS, Journal of clinical oncology, 14(3), 1996, pp. 955-962
SERUM INTERLEUKIN-11 IN PLASMA-CELL DYSCRASIAS
Authors: STASI R BRUNETTI M BUSSA S CATUCCI AE PAGANO A AMADORI S
Citation: R. Stasi et al., SERUM INTERLEUKIN-11 IN PLASMA-CELL DYSCRASIAS, American journal of hematology, 53(3), 1996, pp. 206-207
ANALYSIS OF LYMPHOID ANTIGEN EXPRESSION IN 271 CASES OF ACUTE MYELOIDLEUKEMIAS
Authors: VENDITTI A DELPOETA G BUCCISANO F TAMBURINI AA BRUNO A COX C MAFFEI L SIMEONE MD AMADORI S PAPA G
Citation: A. Venditti et al., ANALYSIS OF LYMPHOID ANTIGEN EXPRESSION IN 271 CASES OF ACUTE MYELOIDLEUKEMIAS, Experimental hematology, 24(9), 1996, pp. 546-546
INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS
Authors: DEWITTE T SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J
Citation: T. Dewitte et al., INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS, Experimental hematology, 24(9), 1996, pp. 678-678
HIGH-DOSE CHEMOTHERAPY IN ADULT ACUTE MYELOID-LEUKEMIA - RATIONALE AND RESULTS
Authors: STASI R VENDITTI A DELPOETA G ARONICA G ABRUZZESE E PISANI F CECCONI M MASI M AMADORI S
Citation: R. Stasi et al., HIGH-DOSE CHEMOTHERAPY IN ADULT ACUTE MYELOID-LEUKEMIA - RATIONALE AND RESULTS, Leukemia research, 20(7), 1996, pp. 535-549
A NEW SACCHETTIAN SOURCE -CENTURY ITALIAN POET AND WRITER - THE 'LIBER DE INTRODUCTIONE LOQUENDI' OF FILIPPINO-DA-FERRARA OP( SACCHETTI,FRAN CO, 14TH)
Authors: AMADORI S
Citation: S. Amadori, A NEW SACCHETTIAN SOURCE -CENTURY ITALIAN POET AND WRITER - THE 'LIBER DE INTRODUCTIONE LOQUENDI' OF FILIPPINO-DA-FERRARA OP( SACCHETTI,FRAN CO, 14TH), Lettere Italiane, 48(3), 1996, pp. 420-436
INTENSIVE TREATMENT OF PATIENTS AGE 60 YEARS AND OLDER WITH DE-NOVO ACUTE MYELOID-LEUKEMIA - ANALYSIS OF PROGNOSTIC FACTORS
Authors: STASI R VENDITTI A DELPOETA G ARONICA G DENTAMARO T CECCONI M STIPA E SCIMO MT MASI M AMADORI S
Citation: R. Stasi et al., INTENSIVE TREATMENT OF PATIENTS AGE 60 YEARS AND OLDER WITH DE-NOVO ACUTE MYELOID-LEUKEMIA - ANALYSIS OF PROGNOSTIC FACTORS, Cancer, 77(12), 1996, pp. 2476-2488
ANALYSIS OF LYMPHOID ANTIGEN EXPRESSION IN 271 CASES OF ACUTE MYELOIDLEUKEMIAS
Authors: VENDITTI A DELPOETA G BUCCISANO F TAMBURINI A",ARONICA,"BRUNO A COX C MAFFEI L SIMONE MD PAPA G AMADORI S
Citation: A. Venditti et al., ANALYSIS OF LYMPHOID ANTIGEN EXPRESSION IN 271 CASES OF ACUTE MYELOIDLEUKEMIAS, Blood, 88(10), 1996, pp. 321-321
HIGH PROLIFERATIVE RATE DETECTED BY TRANSFERRIN RECEPTOR IS ASSOCIATED BOTH WITH LOW-INTENSITY OF BCL-2 EXPRESSION AND POOR OUTCOME IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: DELPOETA G VENDITTI A ARONICA G COX MC BRUNO A BUCCISANO F TAMBURINI A SUPPO G SIMONE MD CORDERO V TUFILLI V MAFFEI L AMADORI S
Citation: G. Delpoeta et al., HIGH PROLIFERATIVE RATE DETECTED BY TRANSFERRIN RECEPTOR IS ASSOCIATED BOTH WITH LOW-INTENSITY OF BCL-2 EXPRESSION AND POOR OUTCOME IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 330-330
FISH ANALYSIS IS MORE RELIABLE THAN RT-PCR FOR THE DIAGNOSIS OF BCR ABL+ LEUKEMIAS/
Authors: COX MC MAFFEI L BUFFOLINO S DELPOETA G BRUNO T CANTONETTI M VENDITTI A ARONICA G BRUNO A LENTINI R AQUILINA P MASI M GIUDICEANDREA P TRIBALTO M AMADORI S
Citation: Mc. Cox et al., FISH ANALYSIS IS MORE RELIABLE THAN RT-PCR FOR THE DIAGNOSIS OF BCR ABL+ LEUKEMIAS/, Blood, 88(10), 1996, pp. 1472-1472
THE INFLUENCE OF CYTOGENETIC ABNORMALITIES ON TREATMENT OUTCOME AFTERINTENSIVE ANTILEUKEMIC THERAPY FOR PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS
Authors: DEWITTE,"SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S JEHN U MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J
Citation: S. Dewitte,"suciu et al., THE INFLUENCE OF CYTOGENETIC ABNORMALITIES ON TREATMENT OUTCOME AFTERINTENSIVE ANTILEUKEMIC THERAPY FOR PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS, Blood, 88(10), 1996, pp. 1806-1806
THE PROGNOSTIC IMPACT OF THE PRESENCE OF AN HLA-IDENTICAL DONOR ON PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS TREATED WITH AN INTENSIVE ANTILEUKEMIC REGIMEN
Authors: MATTIJSSEN V",DEWITTE,"SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S JEHN U MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J
Citation: S. Mattijssen V",dewitte,"suciu et al., THE PROGNOSTIC IMPACT OF THE PRESENCE OF AN HLA-IDENTICAL DONOR ON PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS TREATED WITH AN INTENSIVE ANTILEUKEMIC REGIMEN, Blood, 88(10), 1996, pp. 1908-1908
WHICH TREATMENT IS PREFERABLE FOR ANAPLASTIC LARGE-CELL LYMPHOMA-HODGKINS-LIKE (ALCL-HL) - MACHOP-B OR ABVD
Authors: ZINZANI PL MARTELLI M PILERI S VOLPE E GOBBI M GALIENI P AMADORI S LEONE G MORETTI L MAZZA P GHERLINZONI F BENDANDI M DESANCTIS V CARUSO R MANDELLI F TURA S
Citation: Pl. Zinzani et al., WHICH TREATMENT IS PREFERABLE FOR ANAPLASTIC LARGE-CELL LYMPHOMA-HODGKINS-LIKE (ALCL-HL) - MACHOP-B OR ABVD, Blood, 88(10), 1996, pp. 2274-2274
CLINICAL RELEVANCE OF P-GLYCOPROTEIN EXPRESSION IN DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: DELPOETA G STASI R ARONICA G VENDITTI A COX MC BRUNO A BUCCISANO F MASI M TRIBALTO M AMADORI S PAPA G
Citation: G. Delpoeta et al., CLINICAL RELEVANCE OF P-GLYCOPROTEIN EXPRESSION IN DE-NOVO ACUTE MYELOID-LEUKEMIA, Blood, 87(5), 1996, pp. 1997-2004
BIOLOGICAL PROFILE OF 23 CASES OF MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) AND ITS CLINICAL IMPLICATIONS
Authors: VENDITTI A DELPOETA G STASI R BUCCISANO F ARONICA G BRUNO A COX C MAFFEI L TAMBURINI A PAPA G AMADORI S
Citation: A. Venditti et al., BIOLOGICAL PROFILE OF 23 CASES OF MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) AND ITS CLINICAL IMPLICATIONS, Blood, 87(1), 1996, pp. 418-420
MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE) - AN EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA
Authors: VISANI G PETTI MC CENACCHI A MANFROI S TOSI P SPADEA A LATAGLIATA R AMADORI S MANDELLI F TURA S
Citation: G. Visani et al., MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE) - AN EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA, Leukemia & lymphoma, 19(5-6), 1995, pp. 447-451
MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS
Authors: MAZZA P ZINZANI PL MARTELLI M FIACCHINI M BOCCHIA M PILERI S FALINI B MARTELLI MF AMADORI S PAPA G CANTONETTI M LUCARELLI G MORETTI L CALABRESI F RUGGERI E GHERLINZONI F BENDANDI M GUGLIELMI C BURGIO V DAMMACCO F LAUTA VM LIBERATI AM MANDELLI F TURA S
Citation: P. Mazza et al., MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 16(5-6), 1995, pp. 457-463
CONTRIBUTION OF IMMUNOPHENOTYPIC - AND GENOTYPIC ANALYSES TO THE DIAGNOSIS OF ACUTE-LEUKEMIA
Authors: STASI R TAYLOR CG VENDITTI A DELPOETA G ARONICA G BASTIANELLI C SIMONE MD BUCCISANO F COX MC BRUNO A PICCIONI D ABRUZZESE E SARGENT JM TRIBALTO M AMADORI S
Citation: R. Stasi et al., CONTRIBUTION OF IMMUNOPHENOTYPIC - AND GENOTYPIC ANALYSES TO THE DIAGNOSIS OF ACUTE-LEUKEMIA, Annals of hematology, 71(1), 1995, pp. 13-27
THERAPY-RELATED ACUTE MYELOMONOCYTIC LEUKEMIA FOLLOWING SUCCESSFUL TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA
Authors: TODISCO E TESTI AM AVVISATI G MOLETI ML CEDRONE M CIMINO G MANCINI F AMADORI S MANDELLI F
Citation: E. Todisco et al., THERAPY-RELATED ACUTE MYELOMONOCYTIC LEUKEMIA FOLLOWING SUCCESSFUL TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia, 9(9), 1995, pp. 1583-1585
ALL-TRANS-RETINOIC ACID (ATRA) ADMINISTRATION DURING PREGNANCY IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA
Authors: SIMONE MD STASI R VENDITTI A DELPOETA G ARONICA G BRUNO A MASI M TRIBALTO M PAPA G AMADORI S
Citation: Md. Simone et al., ALL-TRANS-RETINOIC ACID (ATRA) ADMINISTRATION DURING PREGNANCY IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia, 9(8), 1995, pp. 1412-1413
ALL-TRANS-RETINOIC ACID AND LOW-DOSE CYTOSINE-ARABINOSIDE FOR THE TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA
Authors: VENDITTI A STASI R DELPOETA G BUCCISANO F ARONICA G BRUNO A PISANI F CARAVITA T MASI M TRIBALTO M SIMONE MD AVVISATI G AMADORI S PAPA G
Citation: A. Venditti et al., ALL-TRANS-RETINOIC ACID AND LOW-DOSE CYTOSINE-ARABINOSIDE FOR THE TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA, Leukemia, 9(7), 1995, pp. 1121-1125
Risultati: 1-25 | 26-50 | 51-75 | 76-100 >>